Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Public ClinicalTrials.gov record NCT01485796. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) Facilitated Subcutaneous Treatment With Immune Globulin Infusion (Human), 10% in Subjects With Primary Immunodeficiency Diseases (PIDD)
Study identification
- NCT ID
- NCT01485796
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Baxalta now part of Shire
- Industry
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- Immune Globulin Infusion (Human), 10% Biological
- Recombinant human hyaluronidase Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 28, 2011
- Primary completion
- Dec 31, 2012
- Completion
- Dec 31, 2012
- Last update posted
- May 18, 2021
2011 – 2013
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Irvine | Irvine | California | 92697 | — |
| IMMUNOe International Research Centers | Thornton | Colorado | 80233 | — |
| Allergy Associates of the Palm Beaches, PA | North Palm Beach | Florida | 33408 | — |
| LSU Health Sciences Center & Children´s Hospital | New Orleans | Louisiana | 70118 | — |
| Midwest Immunology | Plymouth | Minnesota | 55446 | — |
| Midlands Pediatrics PC | Papillion | Nebraska | 68046 | — |
| Winthrop Allergy and Immunology | Mineola | New York | 11501 | — |
| Oklahoma Institute of Allergy & Asthma Clinical Research | Oklahoma City | Oklahoma | 73131 | — |
| Allergy and Clinical Immunology Associates | Pittsburgh | Pennsylvania | 15241 | — |
| Allergy, Asthma & Immunology Clinic PA | Irving | Texas | 75063 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01485796, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2021 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01485796 live on ClinicalTrials.gov.